Ian Maddock Hanson

Ian Maddock Hanson

Auto-generated profile, based on publicly available information

Ian Maddock Hanson

Physics Department, Royal Marsden Hospital, Downs Road, SUTTON, Surrey, SM2 5PT, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2007 in Science
Verified
Journal Article
Closed access
PDF file
MKMarkku Kulmala
Markku Kulmala
IRIlona Riipinen
Ilona Riipinen
MSMikko Sipilä
Mikko Sipilä
HMHanna E. Manninen
Hanna E. Manninen
TPTuukka Petäjä
Tuukka Petäjä
VKVeli-Matti Kerminen
Veli-Matti Kerminen
Atmospheric aerosol formation is known to occur almost all over the world, and the importance of these particles to climate and air quality has been recognized. Although almost all of the processes driving aerosol formation take place below a particle diameter of 3 nanometers, observations cover only larger particles. We introduce an instrumental setup to measure atmospheric concentrations of both neutral and charged nanometer-sized clusters. By applying the instruments in the field, we come to three important conclusions: (i) A pool of numerous neutral clusters in the sub–3 nanometer size range is continuously present; (ii) the processes initiating atmospheric aerosol formation start from particle sizes of ∼1.5 nanometers; and (iii) neutral nucleation dominates over the ion-induced mechanism, at least in boreal forest conditions.

1 January 2018 in Physics in Medicine & Biology
Verified
Journal Article
Open access
PDF file
JBJames L Bedford
James L Bedford
IHIan Maddock Hanson
Ian Maddock Hanson
VHVibeke N Hansen
Vibeke N Hansen

24 January 2014 in Medical Physics
Verified
Journal Article
Closed access
JBJames L. Bedford
James L. Bedford
IHIan M. Hanson
Ian M. Hanson
VHVibeke Nordmark Hansen
Vibeke Nordmark Hansen

2 February 2018 in Physics in Medicine & Biology
Verified
Journal Article
Open access
PDF file
FCFilipa Costa
Filipa Costa
SDSimon Doran
Simon Doran
IHIan Maddock Hanson
Ian Maddock Hanson
SNSimeon Nill
Simeon Nill
IBIlias Billas
Ilias Billas
UOUwe Oelfke
Uwe Oelfke
Dosimetric quality assurance (QA) of the new Elekta Unity (MR-linac) will differ from the QA performed of a conventional linac due to the constant magnetic field, which creates an electron return effect (ERE). In this work we aim to validate PRESAGE(R) dosimetry in a transverse magnetic field, and assess its use to validate the research version of the Monaco TPS of the MR-linac. Cylindrical samples of PRESAGE(R) 3D dosimeter separated by an air gap were irradiated with a cobalt-60 unit, while placed between the poles of an electromagnet at 0.5 T and 1.5 T. This set-up was simulated in EGSnrc/Cavity Monte Carlo (MC) code and relative dose distributions were compared with measurements using 1D and 2D gamma criteria of 3% and 1.5mm. The irradiation conditions were adapted for the MR-linac and compared with Monaco TPS simulations. Measured and EGSnrc/Cavity simulated profiles showed good agreement with a gamma passing rate of 99.9% for 0.5T and 99.8% for 1.5T. Measurements on the MR-linac also compared well with Monaco TPS simulations, with a gamma passing rate of 98.4% at 1.5T. Results demonstrated that PRESAGE(R) can accurately measure dose and detect the ERE, encouraging its use as a QA tool to validate the Monaco TPS of the MR-linac for clinically relevant dose distributions at tissue-air boundaries.

11 September 2014 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
IHIan M Hanson
Ian M Hanson
VHVibeke N Hansen
Vibeke N Hansen
IOIgor Olaciregui-Ruiz
Igor Olaciregui-Ruiz
MHMarcel van Herk
Marcel van Herk
Using an Electronic Portal Imaging Device (EPID) to perform in-vivo dosimetry is one of the most effective and efficient methods of verifying the safe delivery of complex radiotherapy treatments. Previous work has detailed the development of an EPID based in-vivo dosimetry system that was subsequently used to replace pre-treatment dose verification of IMRT and VMAT plans. Here we show that this system can be readily implemented on a commercial megavoltage imaging platform without modification to EPID hardware and without impacting standard imaging procedures. The accuracy and practicality of the EPID in-vivo dosimetry system was confirmed through a comparison with traditional TLD in-vivo measurements performed on five prostate patients.The commissioning time required for the EPID in-vivo dosimetry system was initially prohibitive at approximately 10 h per linac. Here we present a method of calculating linac specific EPID dosimetry correction factors that allow a single energy specific commissioning model to be applied to EPID data from multiple linacs. Using this method reduced the required per linac commissioning time to approximately 30 min.The validity of this commissioning method has been tested by analysing in-vivo dosimetry results of 1220 patients acquired on seven linacs over a period of 5 years. The average deviation between EPID based isocentre dose and expected isocentre dose for these patients was (-0.7 ± 3.2)%.EPID based in-vivo dosimetry is now the primary in-vivo dosimetry tool used at our centre and has replaced nearly all pre-treatment dose verification of IMRT treatments.

12 September 2016 in STAR: Science & Technology of Archaeological Research
Verified
Journal Article
Open access
LELaura Helen Evis
Laura Helen Evis
IHIan Hanson
Ian Hanson
PCPaul Nicholas Cheetham
Paul Nicholas Cheetham
The process of archaeological excavation is one of destruction. It normally provides archaeologists with a singular opportunity to recognise, define, extract and record archaeological evidence: the artefacts, features and deposits present in the archaeological record. It is expected that when archaeologists are excavating in a research, commercial or forensic setting the methods that they utilise will ensure a high rate of evidence recognition and recovery. Methods need to be accepted amongst the archaeological and scientific community they are serving and be deemed reliable. For example, in forensic contexts, methods need to conform to scientific and legal criteria so that the evidence retrieved is admissible in a court of law. Two standard methods of grave excavation were examined in this study with the aim of identifying the better approach in terms of evidence recovery. Four archaeologists with a range of experience each excavated two similarly constructed experimental ‘single graves’ using two different excavation methods. Those tested were the arbitrary level excavation method and the stratigraphic excavation method. The results from the excavations were used to compare recovery rates for varying forms of evidence placed within the graves. The stratigraphic excavation method resulted in higher rates of recovery for all evidence types, with an average of 71% of evidence being recovered, whereas the arbitrary level excavation method recovered an average of 56%. Neither method recovered all of the evidence. These findings raise questions about the reliability and so suitability of these established approaches to excavation.